Prothena | Ventes



Sales Changement Date
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
Agios Pharmaceuticals USD 8.7M 2.03M 2025-03
ALKERMES USD 306.5M 123.5M 2025-03
Alnylam Pharmaceuticals USD 594.19M 1.02M 2025-03
Amgen USD 8.15B 936M 2025-03
Biogen USD 2.43B 24.7M 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Exelixis USD 566.76M 27.21M 2024-12
Incyte USD 1.05B 128.7M 2025-03
Ionis Pharmaceuticals USD 132M 94.58M 2025-03
MacroGenics USD 19.35M 91.35M 2024-12
Neurocrine Biosciences USD 572.6M 55.1M 2025-03
Prothena USD 2.12M 1.15M 2024-12
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
Vertex Pharmaceuticals USD 2.77B 142M 2025-03



Prothena Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.